Construction of an immunogenic cell death-related LncRNA signature to predict the prognosis of patients with lung adenocarcinoma.

Autor: Wang, Shuaishuai¹ (AUTHOR) wss19931212@163.com, Zhang, Yi² (AUTHOR)

Publikováno v: BMC Medical Genomics. 11/27/2024, Vol. 17 Issue 1, p1-12. 12p.

High CTLA-4 gene expression is an independent good prognosis factor in breast cancer patients, especially in the HER2-enriched subtype.

Autor: Montoyo-Pujol, Yoel G.^1,2 (AUTHOR) montoyo_yoe@isabial.es, Ponce, José J.² (AUTHOR), Delgado-García, Silvia³ (AUTHOR), Martín, Tina A.³ (AUTHOR), Ballester, Hortensia³ (AUTHOR), Castellón-Molla, Elena⁴ (AUTHOR), Ramos-Montoya, Angela³ (AUTHOR), Lozano-Cubo, Inmaculada² (AUTHOR), Sempere-Ortells, J. Miguel^1,5 (AUTHOR), Peiró, Gloria^1,4,5 (AUTHOR) peiro_glo@gva.es

Publikováno v: Cancer Cell International. 11/10/2024, Vol. 24 Issue 1, p1-17. 17p.

Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients.

Autor: Catacchio I; Functional Biomorphology Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II' di Bari, Italia. Electronic address: ivana.84@libero.it., Silvestris N; Medical Oncology Unit and Scientific Directorate IRCCS Istituto Tumori 'Giovanni Paolo II' di Bari, Italia. Electronic address: silvestrisnicola@libero.it., Scarpi E; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)-IRCCS, 47014 Meldola, FC, Italy. Electronic address: emanuela.scarpi@irst.emr.it., Schirosi L; Functional Biomorphology Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II' di Bari, Italia. Electronic address: l.schirosi@oncologico.bari.it., Scattone A; Pathology Department, IRCCS Istituto Tumori 'Giovanni Paolo II' di Bari, Italia. Electronic address: a.scattoneanatopat@alice.it., Mangia A; Functional Biomorphology Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II' di Bari, Italia. Electronic address: a.mangia@oncologico.bari.it.

Publikováno v: Translational oncology [Transl Oncol] 2019 Mar; Vol. 12 (3), pp. 585-595. Date of Electronic Publication: 2019 Jan 22.

Purification and characterization of two novel Hemiscorpius lepturus scorpion venom-derived phospholipases A2 which inhibit angiogenesis in vitro

Autor: Jridi, I., Catacchio, I., Majdoub, H., Villard, C., Shahbazzadeh, D., El Ayeb, M., Vacca, A., Borchani, L.

Publikováno v: In Toxicon 15 June 2016 116:76-77

NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.

Autor: Saponaro C; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy., Vagheggini A; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)-IRCCS, 47014, Meldola, FC, Italy., Scarpi E; Unit of Biostatistics and Clinical Trials, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST)-IRCCS, 47014, Meldola, FC, Italy., Centonze M; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy., Catacchio I; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy., Popescu O; Pathology Department, IRCCS-Istituto Tumori 'Giovanni PaoloII', 70124, Bari, Italy., Pastena MI; Pathology Department, IRCCS-Istituto Tumori 'Giovanni PaoloII', 70124, Bari, Italy., Giotta F; Medical Oncology Unit, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy., Silvestris N; Scientific Direction, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy., Mangia A; Functional Biomorphology Laboratory, IRCCS-Istituto Tumori 'Giovanni Paolo II', 70124, Bari, Italy. a.mangia@oncologico.bari.it.

Publikováno v: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2018 May 02; Vol. 37 (1), pp. 96. Date of Electronic Publication: 2018 May 02.